Literature DB >> 20290164

The treatment of psychopaths and borderline patients.

M SCHMIDEBERG.   

Abstract

Entities:  

Keywords:  PERSONALITY/psychopathic

Mesh:

Year:  1947        PMID: 20290164     DOI: 10.1176/appi.psychotherapy.1947.1.1.45

Source DB:  PubMed          Journal:  Am J Psychother        ISSN: 0002-9564


× No keyword cloud information.
  9 in total

1.  Differential psychotherapy of borderline states.

Authors:  V W EISENSTEIN
Journal:  Psychiatr Q       Date:  1951-07

2.  Stability and fluctuation of personality disorder features in daily life.

Authors:  Aidan G C Wright; Leonard J Simms
Journal:  J Abnorm Psychol       Date:  2016-05-19

Review 3.  Diagnostic concepts concerning patients demonstrating both psychotic and neurotic symptoms.

Authors:  J Weisfogel; R Dickes; R C Simons
Journal:  Psychiatr Q       Date:  1969

4.  Daily Interpersonal and Affective Dynamics in Personality Disorder.

Authors:  Aidan G C Wright; Christopher J Hopwood; Leonard J Simms
Journal:  J Pers Disord       Date:  2015-08

Review 5.  Psychotherapy of borderline personality disorder.

Authors:  M C Zanarini
Journal:  Acta Psychiatr Scand       Date:  2009-11       Impact factor: 6.392

6.  Borderline personality disorder: are proliferative symptoms characteristic?

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Psychiatry (Edgmont)       Date:  2008-08

7.  Borderline personality disorder: stress reactivity or stress generation? A prospective dimensional study.

Authors:  Timothy A Allen; Alexandre Y Dombrovski; Paul H Soloff; Michael N Hallquist
Journal:  Psychol Med       Date:  2020-07-27       Impact factor: 7.723

8.  The prevalence of borderline personality symptoms in adolescents.

Authors:  Mohammad Reza Mohammadi; Morteza Shamohammadi; Maryam Salmanian
Journal:  Iran J Psychiatry       Date:  2014-07

9.  Exploring schizophrenia spectrum psychopathology in borderline personality disorder.

Authors:  Maja Zandersen; Josef Parnas
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-07-09       Impact factor: 5.270

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.